Kaul Inderjit 4

What Happened

• Inderjit Kaul, a non‑employee director of Minerva Neurosciences (NERV), was granted a derivative award covering 50,000 shares on 2026-06-03. The filing reports a price of $0.00 for the acquisition (transaction code A). This is a grant of an equity‑based award (an option or similar derivative), not an open‑market purchase or sale.

Key Details

• Transaction date: 2026-06-03. Form 4 filed: 2026-06-05 (timely within the standard 2‑business‑day window).
• Reported amount: 50,000 shares; reported price: $0.00.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnote (vesting): The award vests in four equal quarterly installments (1/4 every three months). The first 1/4 vests three months after June 3, 2026 (around 2026-09-03), with additional 1/4 vesting every three months thereafter, subject to continued service as a non‑employee director.
• Filing type: Grant/award (A). No indication the award was immediately exercised or sold.

Context

• This is a typical director compensation award that vests over time; it does not reflect an immediate cash purchase or sale. The economic value to the director will depend on any exercise price and future stock performance (the filing reports $0.00, but actual realized value will depend on plan terms and market conditions).
• Because this is a standard compensation grant to a board member and was filed promptly, it should be viewed as routine insider compensation rather than a direct bullish or bearish signal.